Modulation of the endoplasmic reticulum–mitochondria interface in Alzheimer’s disease and related models
-
- Louise Hedskog
- Department of Neurobiology, Care Sciences and Society, Karolinska Institutet-Alzheimer’s Disease Research Center, Karolinska Institutet, 141 86 Stockholm, Sweden;
-
- Catarina Moreira Pinho
- Department of Biochemistry and Biophysics, Stockholm University, 106 91 Stockholm, Sweden;
-
- Riccardo Filadi
- Department of Biomedical Sciences, University of Padua, 35121 Padua, Italy;
-
- Annica Rönnbäck
- Department of Neurobiology, Care Sciences and Society, Karolinska Institutet-Alzheimer’s Disease Research Center, Karolinska Institutet, 141 86 Stockholm, Sweden;
-
- Laura Hertwig
- Department of Neurobiology, Care Sciences and Society, Karolinska Institutet-Alzheimer’s Disease Research Center, Karolinska Institutet, 141 86 Stockholm, Sweden;
-
- Birgitta Wiehager
- Department of Neurobiology, Care Sciences and Society, Karolinska Institutet-Alzheimer’s Disease Research Center, Karolinska Institutet, 141 86 Stockholm, Sweden;
-
- Pia Larssen
- Department of Neurobiology, Care Sciences and Society, Karolinska Institutet-Alzheimer’s Disease Research Center, Karolinska Institutet, 141 86 Stockholm, Sweden;
-
- Sandra Gellhaar
- Department of Neuroscience, Karolinska Institutet, 171 65 Stockholm, Sweden; and
-
- Anna Sandebring
- Department of Neurobiology, Care Sciences and Society, Karolinska Institutet-Alzheimer’s Disease Research Center, Karolinska Institutet, 141 86 Stockholm, Sweden;
-
- Marie Westerlund
- Department of Neurobiology, Care Sciences and Society, Karolinska Institutet-Alzheimer’s Disease Research Center, Karolinska Institutet, 141 86 Stockholm, Sweden;
-
- Caroline Graff
- Department of Neurobiology, Care Sciences and Society, Karolinska Institutet-Alzheimer’s Disease Research Center, Karolinska Institutet, 141 86 Stockholm, Sweden;
-
- Bengt Winblad
- Department of Neurobiology, Care Sciences and Society, Karolinska Institutet-Alzheimer’s Disease Research Center, Karolinska Institutet, 141 86 Stockholm, Sweden;
-
- Dagmar Galter
- Department of Neuroscience, Karolinska Institutet, 171 65 Stockholm, Sweden; and
-
- Homira Behbahani
- Department of Neurobiology, Care Sciences and Society, Karolinska Institutet-Alzheimer’s Disease Research Center, Karolinska Institutet, 141 86 Stockholm, Sweden;
-
- Paola Pizzo
- Department of Biomedical Sciences, University of Padua, 35121 Padua, Italy;
-
- Elzbieta Glaser
- Department of Biochemistry and Biophysics, Stockholm University, 106 91 Stockholm, Sweden;
-
- Maria Ankarcrona
- Department of Neurobiology, Care Sciences and Society, Karolinska Institutet-Alzheimer’s Disease Research Center, Karolinska Institutet, 141 86 Stockholm, Sweden;
書誌事項
- 公開日
- 2013-04-25
- DOI
-
- 10.1073/pnas.1300677110
- 公開者
- Proceedings of the National Academy of Sciences
この論文をさがす
説明
<jats:p> It is well-established that subcompartments of endoplasmic reticulum (ER) are in physical contact with the mitochondria. These lipid raft-like regions of ER are referred to as mitochondria-associated ER membranes (MAMs), and they play an important role in, for example, lipid synthesis, calcium homeostasis, and apoptotic signaling. Perturbation of MAM function has previously been suggested in Alzheimer’s disease (AD) as shown in fibroblasts from AD patients and a neuroblastoma cell line containing familial presenilin-2 AD mutation. The effect of AD pathogenesis on the ER–mitochondria interplay in the brain has so far remained unknown. Here, we studied ER–mitochondria contacts in human AD brain and related AD mouse and neuronal cell models. We found uniform distribution of MAM in neurons. Phosphofurin acidic cluster sorting protein-2 and σ1 receptor, two MAM-associated proteins, were shown to be essential for neuronal survival, because siRNA knockdown resulted in degeneration. Up-regulated MAM-associated proteins were found in the AD brain and amyloid precursor protein (APP) <jats:sub>Swe</jats:sub> <jats:sub>/Lon</jats:sub> mouse model, in which up-regulation was observed before the appearance of plaques. By studying an ER–mitochondria bridging complex, inositol-1,4,5-triphosphate receptor–voltage-dependent anion channel, we revealed that nanomolar concentrations of amyloid β-peptide increased inositol-1,4,5-triphosphate receptor and voltage-dependent anion channel protein expression and elevated the number of ER–mitochondria contact points and mitochondrial calcium concentrations. Our data suggest an important role of ER–mitochondria contacts and cross-talk in AD pathology. </jats:p>
収録刊行物
-
- Proceedings of the National Academy of Sciences
-
Proceedings of the National Academy of Sciences 110 (19), 7916-7921, 2013-04-25
Proceedings of the National Academy of Sciences
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1363670320489093760
-
- ISSN
- 10916490
- 00278424
- https://id.crossref.org/issn/00278424
-
- データソース種別
-
- Crossref
